| Field | Specification |
|---|---|
| Gene ID | |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Applications | |
| Conjugate | |
| Concentration | |
| Storage | |
| Storage buffer | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
F4/80 is a 160 kD glycoprotein. It is characterized as a member of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80, also known as EMR1 or Ly71, has been widely used as a murine macrophage marker, which is expressed on the majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen (but not on the macrophages located in T cell areas of the spleen, lymph node and Peyer's patch), Kuffer cells, Langerhans cells, and bone marrow stromal cells. F4/80 has also been shown on a subset of dendritic cells. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for induction of CD8+ T cells-mediated peripheral tolerance.
Validated Applications & Recommended Dilutions
| Application | Recommended Dilution |
|---|---|
| Flow Cytometry | See product datasheet |
Antibody Specifications
| Target | F4/80 |
|---|---|
| Host Species | Rat |
| Clonality | Monoclonal |
| Isotype | Rat IgG2b, κ |
| Conjugate | APC |
| Clone Number | CI:A3-1 |
| Purification | See datasheet |
| Concentration | 5 μL/Test |
Immunogen
Recombinant protein fragment; see full datasheet. UniProt: Q61549.
Species Reactivity & Cross-Reactivity
Validated for: Mouse. Verify suitability in your sample type prior to use. For species or applications not listed in the datasheet, consult our technical team before purchase.
Storage & Handling
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Related Products
Browse additional antibodies targeting F4/80 and complementary reagents — including secondary antibodies, blocking buffers, and detection kits — available through BioHippo.
This antibody is validated for flow cytometry applications. For intracellular targets, fix and permeabilize cells using a validated fixation/permeabilization kit (e.g., BD Cytofix/Cytoperm or similar) before staining. For surface markers, stain live or fixed cells without permeabilization. Always include a matched isotype control (Rat IgG2b, κ, Rat origin) at the same protein concentration as the test antibody to establish non-specific binding thresholds. Recommended starting dilution/concentration: see datasheet.
This antibody has been experimentally validated in: Mouse. Cross-reactivity with other species has not been systematically evaluated. If your sample species is not listed, assess immunogen sequence homology to your target species ortholog. The immunogen used is: "" — higher sequence identity between species increases the probability of cross-reactivity, but experimental validation with appropriate controls is necessary before drawing scientific conclusions.
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.. To maintain antibody activity, avoid repeated freeze-thaw cycles. Aliquot into single-use volumes before first freeze. If working with the antibody frequently, keep a working stock at 4°C for up to 4 weeks — add 0.02% sodium azide to the working stock as a bacteriostatic agent if azide is not already present in the buffer. Monitor performance against a validated positive control when transitioning between storage aliquots or lots.
This monoclonal antibody (clone CI:A3-1) provides highly consistent, epitope-specific recognition of F4/80, making it ideal for quantitative assays, multiplex panels, and studies requiring strict reproducibility across experiments and independent laboratories. Unlike polyclonal preparations, each production batch from a single hybridoma clone generates antibody with identical epitope specificity, affinity, and isotype — ensuring reliable signal comparison in longitudinal studies or multi-site collaborations. When citing this antibody in publications, include the clone designation (clone CI:A3-1) to enable third-party reproducibility verification.
Customization & Add-ons: Can't find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
The browning and mobilization of subcutaneous white adipose tissue supports efficient skin repair (2024) Cell Metabolism. 10.1016/j.cmet.2024.05.005
Propionibacterium acnes Cloaked with ZnAl Layered Double Hydroxides Synergistically Inhibits Tumor Growth and Metastasis (2023) ADVANCED FUNCTIONAL MATERIALS. 10.1002/adfm.202214105
Photosynthetic Plant-Derived Nanovesicles Precisely Amplify Photodynamic Effect by Light-Activated Oxygen Generation for Enhanced Cancer Photoimmunotherapy (2025) ACS Nano. 10.1021/acsnano.5c13350
Remodeling the Tumor Microenvironment: An Emerging Paradigm for Reinvigorating Immunologically Cold Tumors and Advancing Cancer Immunotherapy (2025) ACS Nano. 10.1021/acsnano.5c14644
Neoantigens combined with in situ cancer vaccination induce personalized immunity and reshape the tumor microenvironment (2025) Nature Communications. 10.1038/s41467-025-60448-3
Optically controllable nanoregulators enable tumor-specific pro-ferroptosis lipometabolic reprogramming for in-situ adjuvant-free vaccination (2025) BIOMATERIALS. 10.1016/j.biomaterials.2025.123096
Arginine-assembly as NO nano-donor prevents the negative feedback of macrophage repolarization by mitochondrial dysfunction for cancer immunotherapy (2024) BIOMATERIALS. 10.1016/j.biomaterials.2024.122474
Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment (2023) Theranostics. 10.7150/thno.79367
Fusobacterium nucleatum-driven CX3CR1+ PD-L1+ phagocytes route to tumor tissues and reshape tumor microenvironment (2024) Gut Microbes. 10.1080/19490976.2024.2442037
Tumor microenvironment–activated Zn//MnO2 battery for sustained and local electrochemical immunotherapy (2025) Science Advances. 10.1126/sciadv.adu1647
FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression (2023) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 10.1186/s13046-023-02860-5
Homologous magnetic targeted immune vesicles for amplifying immunotherapy via ferroptosis activation augmented photodynamic therapy against glioblastoma (2025) JOURNAL OF CONTROLLED RELEASE. 10.1016/j.jconrel.2025.113816
Multifunctional self-cascade nanoplatform for efficient immunotherapy through synergizing pyroptosis and self-augmented activation of cGAS-STING pathway (2025) JOURNAL OF COLLOID AND INTERFACE SCIENCE. 10.1016/j.jcis.2025.139423
Integration of CoAl-Layered Double Hydroxides on Commensal Bacteria to Enable Targeted Tumor Inhibition and Immunotherapy (2023) ACS Applied Materials & Interfaces. 10.1021/acsami.3c08936
CpG-Conjugated Silver Nanoparticles as a Multifunctional Nanomedicine to Promote Macrophage Efferocytosis and Repolarization for Atherosclerosis Therapy (2023) ACS Applied Materials & Interfaces. 10.1021/acsami.3c11227
Copper-based hollow mesoporous nanogenerator with reactive oxygen species and reactive nitrogen species storm generation for self-augmented immunogenic cell death-mediated triple-negative breast cancer immunotherapy (2025) JOURNAL OF COLLOID AND INTERFACE SCIENCE. 10.1016/j.jcis.2025.02.186
NIR-triggered programmable nanomotor with H2S and NO generation for cascading oncotherapy by three-pronged reinforcing ICD (2025) Materials Today Bio. 10.1016/j.mtbio.2025.101540
A Drug-Free Polysaccharide Hydrogel Encapsulating Iron Oxide Nanoparticles against Postoperative Tumor Recurrence and Metastasis (2026) ACS Applied Materials & Interfaces. 10.1021/acsami.5c17578
Reversing cancer immunosuppression via K+ capture and repolarization of tumor-associated macrophages (2025) Nanoscale Horizons. 10.1039/D5NH00050E
The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cancer (2026) NEOPLASIA. 10.1016/j.neo.2026.101277
Traditional Chinese Medicine (TCM) enhances the therapeutic efficiency of Gemcitabine-loaded injectable hydrogel on postoperative breast cancer through modulating microenvironment (2025) Journal of Materials Chemistry B. 10.1039/D4TB02776K
Effect of genistein supplementation on microenvironment regulation of breast tumors in obese mice (2024) BREAST CANCER RESEARCH. 10.1186/s13058-024-01904-8
SLC31A1 knockdown mitigates post-MI heart failure via regulation of copper metabolism (2026) Frontiers in Immunology. 10.3389/fimmu.2026.1707203
Mertk-driven tunneling nanotube formation in macrophages preserves mitochondrial homeostasis during kidney Ischemia-Reperfusion Attack (2026) BIOCHEMICAL PHARMACOLOGY. 10.1016/j.bcp.2026.117713
Modulation of M1 macrophage polarization by Fe3O4@Cu2-xS engineering for improved tumor immunotherapy and MRI (2026) COLLOIDS AND SURFACES B-BIOINTERFACES. 10.1016/j.colsurfb.2026.115614
